Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Finally, ‘Validated Clean’ Kerrison Rongeurs For Every Patient, Every Time.
  • USA - English


News provided by

Midbrook Medical

Jul 10, 2014, 04:00 ET

Share this article

Share toX

Share this article

Share toX

Conventional Kerrison Rongeurs
Conventional Kerrison Rongeurs

Jackson, MI (PRWEB) July 10, 2014 -- Introduction:
With the average cost to treat a surgical infection now at $20,785.00 [i] and with over 16,500 patient deaths annually from surgical infections,[ii] the pressure is on hospitals to reduce their patients’ risk. Inadequate cleaning of difficult-to-clean surgical instruments has resulted in cross-contamination and surgical site infections.[iii]

The Tempest Washer removed one-hundred percent (100%) of the inoculated Artificial Test Soil (ATS) containing hemoglobin, protein, and carbohydrate after drying for twenty-four (24) hours from all six Clear Flush® Kerrisons.

Post this

Conventional Kerrison Rongeurs are examples of difficult -- or even impossible -- to clean surgical instruments. These instruments are especially challenging to reprocess. Surgeons, O.R. nurses, reprocessing personnel, and instrument manufacturers have long known that conventional Kerrison Rongeurs are the dirtiest, most difficult instrument to decontaminate and clean in a neuro-surgical case.

Midbrook BioMedical received a request from Advanced Instrumentation for Medicine (AIM) to design and conduct a ‘worst case’ scenario decontamination and cleaning validation test on AIM’s unique, flushable Clear Flush® Kerrisons utilizing the patented Tempest Washer. The test was designed specifically to see if the Clear Flush® Kerrisons could be completely decontaminated and cleaned with the Tempest Washer after the Kerrisons had been thoroughly contaminated with Artificial Test Soil (ATS) and allowed to sit for twenty-four (24) hours without manual pre-flushing, pre-soaking, or manual pre-washing.

Background:
In today’s ever-tightening reimbursement environment, the pressure on hospitals to cut reprocessing costs while at the same time reducing surgical infections intensifies daily. Advances in infection control practices include improved operating room ventilation, sterilization methods, barriers, improved surgical technique, and availability of antimicrobial prophylaxis. Despite all of these activities, surgical infections remain a substantial cause of morbidity and mortality among hospitalized patients.[iv]

Microorganisms that remain in Kerrison Rongeurs after reprocessing may contain or produce toxins and other substances that increase their ability to invade a host, produce damage within the host, or survive on or in host tissue. For example, many gram-negative bacteria produce endotoxins, which stimulate cytokine production. In turn, cytokines can trigger the systemic inflammatory response syndrome that sometimes leads to multiple system organ failure. [v]

An early attempt by manufacturers to solve the cleanability and infection issues associated with Kerrison Rongeurs was to introduce ‘take-apart’ style Kerrisons and later on ‘convertible’ style Kerrisons. These Kerrisons could be disassembled (the ‘take-apart’ style) or opened up (the ‘convertible’ style) for easier decontamination and cleaning. According to the manufacturers of these Kerrisons, their major benefit is that once they have been disassembled or opened up, reprocessing personnel can 'visualize' the bioburden inside of the instrument and manually remove it. Regrettably, the human eye is not capable of seeing microscopic bacteria and biofilm on the surface of a surgical instrument.

Being able to 'visualize' the inside of a Kerrison Rongeurs does not ensure a clean instrument (and this is assuming that reprocessing personnel know how to, much less remember or have the time to disassemble, manually clean, and then correctly reassemble the instrument). According to the CDC, the FDA and AAMI, the only way to ensure clean surgical instruments on every reprocessing cycle is only to use instruments whose cleaning instructions (Instructions for Use, or IFUs) have been validated using AAMI and FDA recommended ‘worst case’ decontamination and cleaning validation protocols.

A more recent solution to the cleanability and infection issues with Kerrison Rongeurs was the introduction of the world’s only ‘flushable’ Kerrison Rongeurs. The patented Clear Flush® Kerrison Rongeurs (http://www.aimclearflush.com/) were designed so they do not have to be disassembled or opened up to be thoroughly decontaminated and cleaned on every reprocessing cycle. The unique design incorporates a flush port and an internal channel to provide a fluid pathway to flush out infectious bioburden from the fixed shank, the moveable crossbar, and the internal ‘I’ beam inside the fixed shank.

Removal of infectious bioburden prior to sterilization dramatically reduces the risk of microbial endotoxins that are heat-stable surviving the sterilization cycle, thus allowing a contaminated Kerrison Rongeurs to be returned to surgery and potentially causing an infection. Healthcare staff members often mistakenly believe that sterilization alone adequately prepares instruments for reuse; this is simply not true.[vi]

Testing Procedure:
Midbrook BioMedical received six (6) Clear Flush® Kerrisons (ranging in size from 1mm to 6mm) from AIM for cleaning validation and verification in Midbrook Medical’s Tempest Washer. AIM shipped the instruments with the top bar removed to provide easy access to the internal surfaces for inoculation and testing. AIM Clear Flush® Kerrisons are not designed to be disassembled (i.e., they are not a ‘take-apart’ style Kerrison) and disassembly during normal use is discouraged in the IFUs.

After receiving the instruments, pictures were taken of each instrument prior to any inoculation or cleaning in order to establish a baseline for post-testing comparison.

All instruments were then seeded both inside and out with Healthmark’s Artificial Test Soil (ATS) [vii] containing hemoglobin, protein and carbohydrate to simulate the types of bioburden most frequently encountered in surgical cases. Following the guidelines outlined in AAMI TIR#12, [viii] the ATS serves as the inorganic/organic challenge for this test protocol.

The instruments were then left for twenty-four (24) hours to allow the ATS to dry and harden on the outsides and insides of the instruments to simulate a ‘worst case’ reprocessing scenario.

After the twenty-four (24) hour mark, more pictures were taken of the instruments in order to show that the Test Soil was present and had thoroughly dried and hardened on the instruments. After the Clear Flush® Kerrisons were photographed with the dried and hardened Test Soil, they were reassembled for decontamination and cleaning (again, these instruments are not ‘take-apart’ style instruments and they were only disassembled for the purpose of this test).

The instruments were then put into the Tempest Washer and were connected to the Tempest Washer’s pressure infusion hoses using Midbrook’s exclusive infusion fixation devices. Once all of the Clear Flush® Kerrison infusion ports were connected to the pressure infusion hoses, the Tempest Washer was run through the standard, automatic cannulated cycle.

The jaws of the flushable Kerrisons were in the open, normal position during the entire cleaning cycle. Upon completion of the standard cleaning cycle inside the Tempest, the instruments were air-dried and inspected. Post-cleaning pictures were taken to document the results.

Equipment:
• 6 Clear Flush® Kerrison Rongeurs 8” length, 40 degree up, coated:
     • A70-0162FP (1mm)
     • A70-0330FP (2mm)
     • A70-0332FP (3mm)
     • A70-0334FP (4mm)
     • A70-0336FP (5mm)
     • A70-0338FP (6mm)
• Tempest Washer
• Healthmark Artificial Test Soil (ATS), containing hemoglobin, protein, and carbohydrate
• Sterile Water
• Syringe
• Camera

Test Results:
The Tempest Washer removed one-hundred percent (100%) of the inoculated Artificial Test Soil (ATS) containing hemoglobin, protein, and carbohydrate after drying for twenty-four (24) hours from all six Clear Flush® Kerrisons.

The twenty-four (24) hour inoculation period was designed to replicate a ‘worst case’ scenario from the start of a surgical procedure, the duration of a procedure (which can be up to 14 hours for a liver transplant), transport to decontamination, and the eventual start of the cleaning process.

The Tempest Washer’s three-cycle, hydro-jet flushing coupled with the patented internal venturi design of the Clear Flush® Kerrison flushed all of the test soil, water and enzymatic cleaner out of the open, distal tip of the instrument. The varying sonication and agitation action of the Tempest coupled with the exclusive internal fluid dynamics of the Clear Flush® Kerrison provided for the removal of all of the dried, encrusted test soil on every instrument.

For a cleaning test to be clinically valid, it must be repeatable by anyone at any time. With the automated Tempest Washer and the flushable Clear Flush® Kerrisons, these extraordinary test results can be repeated in any hospital, by any reprocessing personnel, at any time.

Unlike ‘take-apart’ or ‘convertible’ Kerrisons that require special training and two to three minutes per instrument to reprocess (assuming people actually remember or have time to disassemble it, manually clean it and then properly reassemble it), it takes just five seconds to attach a Clear Flush® Kerrison to a Tempest Washer. By utilizing this unique, validated technology, hospitals can eliminate the ‘human variable’ in instrument reprocessing and have the guaranteed assurance of thoroughly decontaminated, surgically clean Kerrisons with a minimum of effort for every patient, every time.

Conclusion:
This ‘worst case’ validation testing* confirms that a Midbrook Tempest Washer combined with Clear Flush® Kerrisons is the new standard for instrument reprocessing. More importantly, this combination virtually eliminates a patient’s risk of contracting a surgical infection from a contaminated instrument.

With this readily available solution to the costly and dangerous problem of surgical infections caused by contaminated Kerrison Rongeurs, you have to ask yourself, why is your hospital still using the dirtiest instrument in the O.R. on your patients? The validated solution to reducing your patients’ risk of contracting a surgical infection caused by difficult, if not impossible to clean Kerrison Rongeurs lies within your hands.

Validation testing & article provided by: Jahan Azizi, BS, CBET, Amanda Simonsen, BA - April 22, 2014
*To see the complete validation test with before & after photos click here http://www.aimclearflush.com or see the attached file.

For more information on these validated, innovative products, go to Midbrook BioMedical’s web site at http://www.midbrookmedical.com/ or the AIM Clear Flush® Kerrison web site at http://www.aimclearflush.com/.

About Midbrook BioMedical:
Midbrook BioMedical is the world-leader in custom-designed, process-specific cleaning and decontamination equipment. Midbrook has applied technology and expertise gained from other industries to solve some of the most pressing issues facing healthcare facilities. Visit our website for details on all Midbrook BioMedical Infection Prevention products.

i Zimlichman E et al. “Health Care-Associated Infections: A Meta-Analysis of Costs and Financial Impact on the US Health Care System.” JAMA Internal Medicine; December 2013;173(22):2039-46
ii http://www.cdc.gov/media/releases/2014/p0326-hospital-patients.html; Centers for Disease Control; March 2014
iii Today Show Investigates; http://www.today.com/health/today-investigates-dirty-surgical-instruments-problem-or-1C9382187; February 2012
iv CDC’s “Guideline for the Prevention of Surgical Site Infection.”; April 1999
v Ibid.
vi “Inadequately Reprocessed Instruments: If It’s Dirty, How Can It Be Clean?” ECRI's Patient Safety Organization Brief (PSO), April 2013.
vii Healthmark Industries, Fraser, MI. h ttp://artificialtestsoil.com/, 2010
viii Association for the Advancement of Medical Instrumentation, Technical Information Report #12, [http://marketplace.aami.org/eseries/scriptcontent/docs/Preview%20Files/tir121009_preview.pdf __title__ ], September 2010

Jamie Crowley, Midbrook Medical, http://www.midbrookmedical.com, 517-787-3481, [email protected]

Modal title

A.I.M. Clear Flush® Kerrison Cleaning Validation Test
View PDF
A.I.M. Clear Flush® Kerrison Cleaning Validation Test
A.I.M. Clear Flush® Kerrison Cleaning Validation Test

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.